0
Number of Americans aged 12+ that will try an illicit drug in their lifetime
Developing preventive countermeasures to protect against bioweapons – starting with Fentanyl
BIOLOGICAL ARMOR
Video
Nov 19, 2025
Video
Oct 22, 2024
Dec 3, 2025
June 26, 2024
Oct 16, 2024
Dec 3, 2025
Dec 3, 2025
Podcast
Oct 28, 2025
Video
Sep 13, 2024
Sep 3, 2024
June 26, 2024
Sep 1, 2024
Sep 2, 2024
Aug 5, 2025
Synthetic drugs are taking more American lives under 45 years old than car accidents, cancer, or heart attacks annually
0
Number of Americans aged 12+ that will try an illicit drug in their lifetime
$0
Cost of the opioid epidemic in the United States in 2023 alone
0
Estimated American overdose casualties every day
Using organic molecules to activate the human immune system
Resulting in a protective shield against bioweapons – starting with Fentanyl
In development to provide 12-18 months of preventive protection
SUBLINGAL TABLET & INTRAMUSCULAR IN DEVELOPMENT
Utilizing well-researched and proven components
*Not an approved FDA product. Product and image are for illustrative purposes only.
ARMR-100
Fentanyl overdose, poisoning, potentially addiction
Preparing Phase 1
1/2 Trial
Q1 2026 Start Date
In development for military, first responders, and opioid use disorder patients
Plan to expand patient population to teenagers, college students, and young adults
ARMR-200
Nitazenes
Protection against a more potent, emerging, global threat: nitazenes
ARMR-300
Medetomidine
Defense against an emerging, non-opioid threat without a current solution: medetomidine
ARMR-400
Carfentanil
Military countermeasure for potential strategic national stockpiles against an ultra-potent, emerging, synthetic threat
ARMR Exploration
New delivery methods, modalities, and populations
Planning improved delivery methods and other forms of improved treatments
Foundational research has already been funded by the Department of War
Actively pursuing further government partnerships, funding, and advancements